Dainippon Sumitomo, Nitto Denko Join To Develop Schizophrenia Patch
This article was originally published in PharmAsia News
Executive Summary
Dainippon Sumitomo Pharma and Nitto Denko have agreed to an alliance to develop a skin patch to deliver the former’s Lonasen (blonanserin) for treating schizophrenia.